Bank of America
BAC
$54.09
+0.17%
Bank of America Corporation is a diversified financial services titan operating across consumer banking, global wealth and investment management, global banking, and global markets, with a $3.5 trillion balance sheet and the second-largest deposit market share in the United States. The firm is distinct for its scale-driven universal banking model, pairing a dominant domestic retail and middle-market franchise with a top-four global investment banking and trading operation that competes directly with the largest Wall Street houses. The current investor narrative is defined by a tug-of-war between improving operating leverage — Q2 2026 revenue rose 5.8% year-over-year to $49.4 billion with net income of $9.07 billion — and a more cautious macro backdrop in which the Fed's recent rate hike offers only modest net interest income benefits while rising deposit costs and credit risk cap sector upside. Recent commentary highlights that the investment banking recovery is real but uneven, with gains concentrated among advisory-heavy firms like Jefferies and Morgan Stanley while universal banks such as BofA lag, leaving investors debating whether BAC's diversified model is a source of resilience or a drag on multiple expansion.…
BAC
Bank of America
$54.09
Related headlines
Investment Opinion: Should I buy BAC Today?
Based on the synthesis of analyst consensus, valuation, and fundamental trends, BAC warrants a Hold rating with a bias toward accumulation on weakness. The analyst consensus is strong buy with a mean rating of 1.5 and an average target price of $67.95, implying 26.4% upside, but the stock's recent 14.14% one-month decline and technical breakdown suggest near-term headwinds. The core thesis is that BAC is a well-capitalized, profitable franchise trading at a reasonable forward PE of 10.22x, but lacks a near-term catalyst to reverse negative momentum.
Supporting evidence includes: 1) Revenue growth of 5.84% YoY in Q2 2026, with net income of $9.07 billion and a net margin of 18.37%, up from 15.25% a year ago. 2) Improving profitability, with gross margin at 61.13% and operating margin at 23.41%, both significantly higher year-over-year. 3) Strong free cash flow of $94.74 billion TTM, funding $6.01 billion in buybacks and $2.33 billion in dividends, with a sustainable 31.3% payout ratio. 4) Attractive valuation: forward PE of 10.22x and PEG of 0.73, below the sector average, with a dividend yield of 2.36%. The implied upside to the average analyst target is 26.4%, and even the low target of $62.00 offers 15.3% upside.
Key risks that could invalidate the thesis include: 1) A continued lag in investment banking recovery, which could keep revenue growth muted. 2) Rising deposit costs and credit deterioration that could compress net interest margins. 3) A breakdown below the 52-week low of $46.12, which would signal a deeper bearish trend. The rating would upgrade to Buy if the stock stabilizes above $55 and investment banking shows clear acceleration, or downgrade to Sell if revenue growth turns negative or credit losses spike. Relative to its history, BAC is fairly valued: the trailing PE of 14.18x is mid-range (7.52x to 23.38x), and the PB of 1.34x is near the high end, suggesting the market already credits the bank for its capital return and book value growth.
Sign up to view all
BAC 12-Month Price Forecast
BAC presents a balanced risk/reward profile: the stock is fundamentally sound with improving margins, strong capital return, and an attractive forward valuation, but near-term momentum is decidedly negative, with the shares down 14.14% in a month and underperforming the market. The analyst community remains overwhelmingly bullish, with a strong buy consensus and a $67.95 average target, suggesting the selloff is overdone. However, the investment banking recovery is uneven, and macro headwinds like rising deposit costs and credit risk could cap upside. I would upgrade to bullish if BAC stabilizes above $55 and Q3 earnings show IB revenue acceleration; I would downgrade to bearish if the stock breaks below $46.12 or if credit metrics deteriorate sharply.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bank of America's 12-month outlook, with a consensus price target around $67.33 and implied upside of +24.5% versus the current price.
Average Target
$67.33
0 analysts
Implied Upside
+24.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$62 - $75
Analyst target range
Bank of America is covered by 21 analysts with a consensus recommendation of strong_buy and a recommendation mean of 1.5, reflecting a decidedly bullish institutional stance. The average price target of $67.95 implies 26.4% upside from the current price of $53.75, a substantial gap that suggests analysts view the recent selloff as an overreaction rather than a fundamental deterioration. The consensus leans strongly bullish, and the estimated EPS average of $6.82 with a range of $6.66 to $7.00 supports the view that earnings power remains intact, while the estimated revenue average of $133.4 billion (range $131.0 billion to $136.2 billion) implies modest but stable top-line growth. The target range spans from a low of $62.00 to a high of $76.00, a spread of $14.00 or roughly 23% of the average target, which signals meaningful disagreement about the pace of the investment banking recovery and the trajectory of net interest income. The high target of $76.00 assumes a successful IB rebound, multiple expansion toward 1.5x book, and accelerating capital returns, while the low target of $62.00 prices in continued margin pressure from deposit costs, a sluggish advisory recovery, and limited multiple re-rating. Institutional ratings show a consistent pattern of reaffirmations rather than upgrades or downgrades, with UBS, JP Morgan, Evercore ISI, Keefe Bruyette & Woods, Truist, Wells Fargo, RBC, and Barclays all maintaining Buy or Outperform ratings through mid-2026, indicating stable conviction even as the stock has sold off. The wide target spread combined with uniformly bullish ratings suggests that analysts see the current weakness as a buying opportunity, but the market's 14.14% one-month decline indicates investors are not yet convinced, creating a potential disconnect that could resolve in either direction depending on upcoming earnings and macro data.
Bulls vs Bears: BAC Investment Factors
The bear case currently has stronger near-term evidence due to BAC's sharp 14.14% one-month decline, significant underperformance versus SPY, and a technical breakdown below key trend anchors. However, the bull case rests on solid fundamentals: expanding margins, a forward PE of 10.22x, and a strong buy consensus with 26.4% upside to the average target. The most important tension is whether the investment banking recovery will broaden to universal banks like BAC or remain concentrated among advisory-focused peers; if BAC's IB franchise gains traction, the stock could re-rate toward the analyst target, but continued lag could keep the shares range-bound or lower. The market is clearly in a wait-and-see mode, with the upcoming earnings season likely to resolve this debate.
Bullish
- Analyst consensus strong buy with 26.4% upside: 21 analysts rate BAC a strong buy (mean 1.5) with an average target of $67.95, implying 26.4% upside from $53.75. The low target of $62.00 still offers 15.3% upside, suggesting the recent selloff is viewed as an overreaction.
- Forward PE of 10.22x is undemanding: BAC trades at a forward PE of 10.22x versus a trailing PE of 14.18x, a 28% compression that implies expected EPS growth. The PEG ratio of 0.73 is below 1.0, signaling undervaluation relative to growth.
- Profitability and margins expanding: Q2 2026 net income was $9.07 billion with a net margin of 18.37%, up from 15.25% in Q2 2025. Gross margin improved to 61.13% from 53.30% a year earlier, and operating margin rose to 23.41% from 16.47%.
- Strong capital return and free cash flow: Trailing free cash flow is $94.74 billion, funding $6.01 billion in quarterly buybacks and $2.33 billion in dividends. The dividend yield of 2.36% is well covered with a 31.3% payout ratio.
Bearish
- Severe relative underperformance and momentum breakdown: BAC has underperformed SPY by 14.73 percentage points over the past month and 11.82 points over three months. The 1-month decline of 14.14% is far worse than the 1-year gain of 6.48%, signaling a sharp trend reversal.
- Investment banking recovery lagging peers: Recent commentary notes that IB gains are concentrated among advisory-heavy firms like Jefferies and Morgan Stanley, while universal banks like BofA lag. This uneven recovery limits a key growth driver.
- Net interest income headwinds persist: The Fed's recent rate hike offers only modest NII benefits, while rising deposit costs and credit risks cap sector upside. BAC's interest coverage ratio of 0.65 highlights sensitivity to rate and credit conditions.
- Revenue growth decelerating and plateauing: Q2 2026 revenue grew 5.84% YoY to $49.39 billion, but sequentially it declined from $49.69 billion in Q4 2025. This plateau suggests limited top-line acceleration.
BAC Technical Analysis
Bank of America is in a late-stage recovery that has rolled over into a corrective downtrend, with the stock up 6.48% over the past year but down 3.93% year-to-date and sitting at $53.75, roughly 35.6% above its 52-week low of $46.12 and 17.6% below its 52-week high of $65.23. That places the shares in the lower-middle of their 52-week range, a positioning that reflects neither the momentum of a breakout nor the deep-value setup of a washed-out low, but rather a market that has lost conviction after a strong spring rally. The 18.39% maximum drawdown from the peak confirms that the uptrend has been decisively interrupted, and with the stock trading below both its 1-year and 6-month trend anchors, the burden of proof now rests with buyers to reclaim lost ground. Short-term momentum has deteriorated sharply, with the 1-month change of -14.14% and 3-month change of -8.48% both deeply negative and materially worse than the 1-year gain of 6.48%, signaling a clear deceleration and potential trend reversal rather than a mere pause. This divergence is amplified by relative strength: BAC has underperformed SPY by 14.73 percentage points over the past month and 11.82 points over three months, while SPY itself gained 0.59% and 3.34% over those same windows, indicating that the weakness is stock-specific rather than purely macro-driven. The 6-month change of +8.85% versus the 1-month collapse suggests the entire spring rally has been given back in a matter of weeks, a velocity of decline that often precedes either a capitulation low or a sustained downtrend. Key technical levels are well defined: the 52-week low at $46.12 is the critical support zone, and a breakdown below it would confirm a bearish trend reversal and likely trigger momentum-driven selling, while the 52-week high at $65.23 represents the resistance that must be reclaimed to restore the uptrend. With a beta of 1.164, BAC is roughly 16% more volatile than the broader market, meaning position sizing should account for amplified moves in both directions, and the current price of $53.75 sits only 16.5% above the 52-week low, leaving limited cushion before a retest of that support. Volume of 35.1 million shares on the latest session suggests active participation in the selloff, reinforcing the importance of watching whether the $53-54 area stabilizes or gives way.
Beta
1.21
1.21x market volatility
Max Drawdown
-18.4%
Largest decline past year
52-Week Range
$46-$65
Price range past year
Annual Return
+7.3%
Cumulative gain past year
| Period | BAC Return | S&P 500 |
|---|---|---|
| 1m | -13.7% | +1.2% |
| 3m | -7.2% | +4.5% |
| 6m | +2.6% | +14.6% |
| 1y | +7.3% | +16.0% |
| ytd | -3.3% | +14.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAC Fundamental Analysis
Bank of America's revenue trajectory remains solidly positive but is decelerating from its recent peak, with Q2 2026 revenue of $49.39 billion representing 5.84% year-over-year growth versus Q2 2025's $46.67 billion, while the sequential trend shows Q1 2026 at $47.89 billion and Q4 2025 at $49.69 billion, indicating a plateau rather than accelerating expansion. Segment data reveals a balanced but unspectacular mix: Global Markets contributed $7.11 billion, Consumer Banking $11.05 billion, Global Wealth and Investment Management $6.71 billion, and Global Banking $6.29 billion, with the markets and consumer franchises carrying the load while investment banking remains the laggard per recent industry commentary. The growth trend implies a mature, rate-sensitive franchise that benefits from scale but lacks a high-growth engine, making the investment case dependent on operating leverage and capital return rather than top-line acceleration. Profitability is robust and improving, with Q2 2026 net income of $9.07 billion, a net margin of 18.37%, and gross margin of 61.13%, up from 53.30% in Q2 2025 and 48.71% in Q3 2024, demonstrating meaningful margin expansion over the past two years. The operating margin of 23.41% in Q2 2026 compares favorably to 16.47% a year earlier, and the trailing net margin of 15.93% reflects a business that has successfully widened spreads and controlled expenses even as revenue growth moderated. For a diversified bank, these margins are healthy and consistent with a well-run universal institution, though the interest coverage ratio of 0.65 and the inherent rate sensitivity of the model mean profitability remains tethered to the yield curve and credit conditions. The balance sheet is highly leveraged, as expected for a bank, with a debt-to-equity ratio of 1.21, a company equity multiplier of 11.62, and a current ratio of just 0.42, but the cash generation is formidable: trailing free cash flow of $94.74 billion and Q2 2026 operating cash flow of $29.04 billion comfortably fund $6.01 billion of quarterly buybacks and $2.33 billion of dividends. The dividend yield of 2.36% with a payout ratio of 31.3% is well covered, and the ROE of 10.06% and ROA of 0.97% are respectable for a money-center bank, though the low ROA reflects the balance-sheet-intensive nature of the business. The primary financial risk is not liquidity but capital intensity and credit exposure, and the Q4 2025 negative operating cash flow of -$22.95 billion serves as a reminder that quarterly cash flows in banking can swing violently with trading and investment activity.
Quarterly Revenue
$49.4B
2026-06
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
61.1%
Latest Quarter
Free Cash Flow
$94.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAC Overvalued?
Because Bank of America is solidly profitable with positive net income of $9.07 billion in Q2 2026 and trailing EPS of $0.0753 on a per-share basis, the PE ratio is the appropriate primary metric, and the stock trades at a trailing PE of 14.18x versus a forward PE of 10.22x. The 28% compression from trailing to forward earnings implies the market expects meaningful EPS growth, consistent with the analyst consensus estimate of $6.82 for the coming year, though the unusually low reported trailing EPS figure suggests the data may reflect a partial-period or adjusted basis that warrants caution in interpretation. The forward PE of 10.22x is undemanding in absolute terms and suggests the market is pricing in solid but not spectacular earnings delivery. Relative to the broader financial services sector, BAC's 1.34x price-to-book ratio and 14.18x trailing PE sit at modest levels, with the PB multiple indicating the market values the bank at only a 34% premium to book value, a discount to the premium multiples commanded by best-in-class peers and a reflection of the sector's neutral outlook amid rising deposit costs and credit risk. The PEG ratio of 0.73 is below 1.0, which on its face suggests the stock is undervalued relative to its growth rate, and the 2.36% dividend yield with a 31.3% payout ratio offers an attractive income component that supports the valuation floor. The EV/EBITDA of 13.48x and price-to-cash-flow of 32.12x are less informative for a bank but do not flag obvious distress. Historically, BAC's PE ratio has ranged from a low of 7.52x in Q3 2023 to a high of 23.38x in Q4 2023, with the current 14.18x sitting in the middle of that band and above the 10.88x seen in Q1 2026 and 11.68x in Q2 2026. The price-to-book ratio of 1.34x is near the upper end of its recent range, which spanned from 0.76x in Q3 2023 to 1.36x in Q2 2026, suggesting the market is pricing in a reasonable but not euphoric level of optimism. The combination of a mid-range PE and a near-range-high PB implies that while earnings-based valuation is not stretched, the market is already crediting the bank for its book value growth and capital return, leaving less room for multiple expansion without a fundamental catalyst.
PE
14.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 8x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks for Bank of America center on its capital intensity and credit exposure. The debt-to-equity ratio of 1.21 and equity multiplier of 11.62 reflect the inherent leverage of a money-center bank, meaning a deterioration in credit quality could disproportionately impact earnings. The interest coverage ratio of 0.65 is low, indicating that a rise in funding costs or a slowdown in net interest income could pressure profitability. Additionally, the Q4 2025 negative operating cash flow of -$22.95 billion highlights the volatility of quarterly cash flows in banking, which can swing violently with trading and investment activity. Revenue concentration in rate-sensitive segments like Global Markets ($7.11 billion) and Consumer Banking ($11.05 billion) further ties performance to macroeconomic conditions.
Market and competitive risks include valuation compression if BAC fails to meet growth expectations. The stock trades at a price-to-book ratio of 1.34x, near the upper end of its recent range, leaving limited room for multiple expansion without a fundamental catalyst. The forward PE of 10.22x is undemanding, but if earnings disappoint, the multiple could contract toward the lower end of its historical range (7.52x in Q3 2023). Competitive pressures are evident in investment banking, where BAC lags advisory-heavy firms like Jefferies and Morgan Stanley, potentially capping market share gains. With a beta of 1.164, BAC is 16% more volatile than the market, and sector rotation away from financials could exacerbate downside. Recent news highlights that rising deposit costs and credit risks keep the sector outlook neutral, limiting upside.
A worst-case scenario would involve a combination of a stalled investment banking recovery, rising credit losses, and a broad market selloff. In this scenario, BAC could retest its 52-week low of $46.12, representing a 14.2% decline from the current price of $53.75. If the analyst low target of $62.00 is breached due to deteriorating fundamentals, the stock could fall further, potentially to the 2023 low valuation multiple of 7.52x trailing earnings, implying a price near $40. However, the 52-week low serves as a critical support level; a breakdown below it would confirm a bearish trend reversal and likely trigger momentum-driven selling, with a realistic downside of -14% to -25% from current levels.
FAQ
The key risks for BAC, ranked by severity, are: 1) Financial risk: high balance sheet leverage (debt-to-equity 1.21, equity multiplier 11.62) and low interest coverage (0.65) make earnings sensitive to credit deterioration and funding costs. 2) Competitive risk: BAC lags in investment banking recovery, with gains concentrated among advisory-heavy firms like Jefferies and Morgan Stanley, potentially capping revenue growth. 3) Macro risk: rising deposit costs and credit risks, as highlighted in recent Fed commentary, could compress net interest margins and increase loan loss provisions. 4) Company-specific risk: the Q4 2025 negative operating cash flow of -$22.95 billion shows quarterly cash flow volatility, and a breakdown below the 52-week low of $46.12 could trigger momentum-driven selling.
The 12-month forecast for BAC is based on three scenarios: bull case (25% probability) targets $68-$76, assuming a successful investment banking recovery and multiple expansion; base case (55% probability) targets $62-$68, assuming gradual IB recovery and stable net interest income; bear case (20% probability) targets $46-$55, assuming stalled IB recovery and rising credit losses. The base case is most likely, with the key assumption that revenue grows 3-5% YoY and EPS meets the $6.82 consensus. The average analyst target of $67.95 aligns with the base case, implying 26.4% upside from the current price of $53.75.
BAC appears undervalued on forward earnings but fairly valued on book value. The forward PE of 10.22x is below the trailing PE of 14.18x and the broader market average, while the PEG ratio of 0.73 suggests the stock is cheap relative to its growth rate. However, the price-to-book ratio of 1.34x is near the upper end of its recent range (0.76x to 1.36x), indicating the market already credits the bank for its book value growth and capital return. Compared to peers, BAC's 1.34x PB is a discount to premium banks but in line with the sector. The valuation implies the market expects modest earnings growth and stable credit conditions; any disappointment could lead to multiple compression toward the 2023 low of 7.52x trailing earnings.
From a risk/reward perspective, BAC is a good buy for value-oriented investors with a medium-to-long-term horizon. The stock trades at a forward PE of 10.22x and a PEG of 0.73, which is attractive relative to its growth prospects, and the analyst consensus is strong buy with a $67.95 average target, implying 26.4% upside. However, the recent 14.14% one-month decline and 14.73% underperformance versus SPY indicate negative momentum, and the biggest downside risk is a break below the 52-week low of $46.12, which would represent a 14.2% loss. For investors comfortable with volatility (beta 1.164) and a 12-18 month horizon, BAC offers a favorable risk/reward, but short-term traders may want to wait for stabilization above $55.
BAC is more suitable for long-term investment (minimum 12-18 months) than short-term trading. The stock's beta of 1.164 and recent 14.14% one-month decline indicate high volatility, making short-term trading risky. The dividend yield of 2.36% and consistent buybacks ($6.01 billion quarterly) provide a steady return for patient investors, while the forward PE of 10.22x and strong buy consensus suggest upside over a longer horizon. Earnings visibility is moderate, with analyst EPS estimates ranging from $6.66 to $7.00 for the coming year. A minimum holding period of 12 months is recommended to ride out sector cycles and benefit from potential multiple expansion.